CSIMarket
 
Assertio Holdings inc   (NASDAQ: ASRT)
 

Assertio Holdings Inc's Suppliers Performance

ASRT's Supply Chain




 
ASRT Costs vs Sales of Suppliers Growth Assertio Holdings Inc's cost of sales deteriorated by -65.18 % year on year, relative to one quarter ago cost of sales fell by -16.99 % in Q1.

More on ASRT Suppliers



Assertio Holdings Inc's cost of sales deteriorated by -65.18 % year on year, compare to one quarter ago cost of sales fell by -16.99 % in Q1.

More on ASRT Suppliers




Assertio Holdings Inc's Comment on Supply Chain


The company relies on single-source suppliers for the active pharmaceutical ingredients (API) and manufacturing of its products, lacking internal commercial-scale manufacturing capabilities. It depends on third-party manufacturers and suppliers, which exposes it to risks including supply disruptions, regulatory compliance challenges, and price increases. In October 2023, the drug product manufacturer for ROLVEDON requested a significant price increase, resulting in renegotiated supply agreements extending through 2027 and a fixed price amendment through 2025. Additionally, the API provider to the INDOCIN contract manufacturer has requested a substantial price increase, despite fixed pricing agreements with the contract manufacturer through July 2028. The company is currently evaluating the impact of these supplier demands and potential future price increases.

Assertio Holdings Inc's Comment on Supply Chain


The company relies on single-source suppliers for the active pharmaceutical ingredients (API) and manufacturing of its products, lacking internal commercial-scale manufacturing capabilities. It depends on third-party manufacturers and suppliers, which exposes it to risks including supply disruptions, regulatory compliance challenges, and price increases. In October 2023, the drug product manufacturer for ROLVEDON requested a significant price increase, resulting in renegotiated supply agreements extending through 2027 and a fixed price amendment through 2025. Additionally, the API provider to the INDOCIN contract manufacturer has requested a substantial price increase, despite fixed pricing agreements with the contract manufacturer through July 2028. The company is currently evaluating the impact of these supplier demands and potential future price increases.







ASRT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Assertio Holdings inc 151.20 102.16 -35.69 53
SUBTOTAL 0.00 0.00 0.00 -


Sources: Assertio Holdings inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Assertio Holdings inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.